OpenAlex
PricingAboutJobs
Log inGet started
Work

EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research

HTML

Year: 2021
Type: review
Source: Pharmacological Research
DOI: 10.1016/j.phrs.2021.105583
Authors: Rui-Fang Dong, Miao-Lin Zhu, Ming-Ming Liu, Yi-Ting Xu, Liu-Liu Yuan, Jing Bian, Yuan-Zheng Xia, Ling-Yi Kong
Institutions: China Pharmaceutical University, State Key Laboratory of Natural Medicine, Jiangsu Cancer Hospital, Guangxi Medical University
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: EGFR mutation, EGFR tyrosine kinase inhibitors, drug resistance, non-small cell lung cancer, T790M mutation, C797S mutation, targeted therapy, resistance mechanisms, precision medicine
SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Ministry of Education of the People's Republic of China, Ministry of Science and Technology of the People's Republic of China, State Key Laboratory of Natural Medicines
OpenAlex ID: W3150192782
FWCI: 4.617
Cites: 187
Cited by: 226
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security